News | RIVM

RIVM updates guidelines for AstraZeneca interval

As of 21 May, RIVM updated the guidelines for the interval between two doses of the AstraZeneca vaccine. The interval can now be between 6 and 14 weeks.

Social well-being is improving, compliance with coronavirus measures remains important

With the recent easing of the coronavirus measures, social contact and well-being are improving again. Compliance with most measures remains stable for now (such as getting tested by the GGD and avoiding crowds) or is decreasing very gradually.

Breast cancer screening resumes on Bonaire after COVID-19 hiatus

Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.

Downward trend remains steady

In the past calendar week, there were 32% fewer hospital admissions of patients with COVID-19 compared to the week before. New arrivals in the ICU were also down by 23% compared to the previous week.

RIVM launches study on Long COVID

This week RIVM launched the Long COVID study. RIVM is asking people in the Netherlands who test positive for COVID-19 to sign up for the study via LongCOVID.rivm.nl within 7 days after their positive test result.

Jonge vrouw laat voor onderzoek weten of ze klachten ervaart

Downward trend continues

In the past calendar week, from 12 to 18 May, there were 21% fewer hospital admissions of patients with COVID-19 compared to the week before. New arrivals in the ICU were also down by 24% compared to the previous week.

Call for global action plan to save our oceans

Scientists involved in the Seas Oceans and Public Health In Europe (SOPHIE) Project have proposed the first steps towards a united global plan to save our oceans, for the sake of human health.

Andrzej-kryszpiniuk

Effects of scrubber discharges remain below environmental standards

Existing environmental standards are not exceeded by the discharge of scrubber wastewater from sea-going vessels.

RIVM launches study on long-term effectiveness of COVID-19 vaccines

RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.

People born in 1962 invited for COVID-19 vaccination

The first people born in 1962 will be receiving an invitation for a COVID-19 vaccination this week. This group involves people who will be turning 59 this year.